|
|
| 論文 |
| 2005年 |
 |
Takiuchi, H., Narahara, H., Tsujinaka, T., Gotoh, M., Kawabe, S., Katsu,
K., Iishi, H., Tatsuta, M., Fujitani, K., Furukawa, H., and Taguchi,T.
: Phase I Study of S-1 Combined with Irinotecan (CPT-11) in Patients with
Advanced Gastric Cancer (OGSG 0002),Jpn. J. Clin. Oncol. 35, 520-525. |
|
K. Fujitani, H. Narahara, H. Takiuchi, T. Tsujinaka, E. Satomi, M. Gotoh,
M. Hirao, H. Furukawa, T. Taguchi: Phase I and pharmacokinetic study of
S-1 combined with weekly paclitaxel in patients with advanced gastric cancer.
Oncology, 69, 414-420. |
|
| 2006年 |
|
H. Imamura, H. Furukawa, S. Iijima, S. Sugihara, T. Tsujinaka, H. Tsukuma
and T. Shimokawa: Multicenter phase II study of antimicrobial prophylaxis
in low-risk patients undergoing distal gastrectomy for gastic cancer. Gastic
Cancer, 9, 32-35. |
|
Imamura H., Ikeda M., Furukawa H., Tsujinaka T., Fujitani K., Kobayashi
K.,Narahara H., Kato M., Imamoto M., Takabayashi A., Tsukuma H.:PhaseII
study of protracted irinotecan infusion and a low-dose cisplatinfor metastatic
gastric cancer. World Journal of Gastroentrrology 1240, 6522-6526 |
|
| 2007年 |
|
Tomita, N., Fukunaga,N., Okamura, S., Narahara, H., Uedo, N, Ishihara,
R., Ishida, H, Furukawa, H., Gotoh, M., Takiuchi, H. (2007). Phase I/II
Study of CPT-11 plus UFT in Patients with Advanced/Recurrent Colorectal
Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG):
Protocol 0102, Jpn. J. Clin. Oncol. 37,521-527. |
|
Imamura, H., Furukawa, H. Iijima, S., Sugihara, S., Tsujinaka, T. Tsukuma,
H. and Shimokawa, T(2007). Multicenter phase II study of 2 weeks administration
with TS-1 followed by 1 week rest against metastatic gastric cancer, Hepatogastroenterology. |
|
Mishima, H. Ikenaga, M. Ishida, H., Iwamoto, S., Morimoto, T. Narahara,
H., Kato, T., Tsujie, M., Kitai, T., Fukunaga, M. Nakanishi, M., Tsujinaka,
T., FUrukawa, H. and Taguchi. T. Multicenter phase II study of irinotecan
plus bolus fluoroutacil/l-leucovorin for metastasic colorectal cancer,
Anticancer risearch, 27, 1003-1008. |
|
Uedo, N., Naraha, H., Ishihar,R. Takiuchi, H., Goto, M., Fujitani, K.,
Hirao, M., Tsujinaka, T. Imano, M., Furukawa, H., Tsukuma, H., and Taguchi,
T. Phase II study of a combination of iIrinotecan and S-1 in patients with
advanced gastric cancer (OGSG0002), Oncology, 73, 65?71. |
|
| 2008年 |
|
Takiuchi, H., Goto, M., Imamura,H. Furukawa, H., Imano, H., Imamoto, H.,
Kimura, Y., Ishida, H., Fujitani, K., Narahara, H., and Shimokawa, T. (2008).
Multi-Center Phase II Study for Combination Therapy with Paclitaxel/Doxifluridine
to Treat Advanced/Recurrent Gastric Cancer Showing Resistance to S-1 (OGSG
0302), Japanese Journal of Clinical Oncology, 38176-181. |
|
Narahara, H., Fujitani, K., Takiuchi, H., Sugimoto, N., Inoue, K., Uedo,
N., Tsukuma, H., Tsujinaka, T., Furukawa, H. and Taguchi, T.(2008) Phase
II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable
or Metastatic Gastric Cancer, Oncology, 74, 37-41 |
|
| 2009年 |
|
Hideyuki Ishida, Yasuhiro Miyake, Mutsumi Fukunaga, Yasunori Watanabe,
Takeshi Kato,Hiroyoshi Takemoto and Hiroshi Furukawa (2010).A Feasibility
Study of UFT/LV and Irinotecan (TEGAFIRI) in Advanced or Metastatic Colorectal
Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG
0304. Japanese Journal of Clinical Oncology, 39, 601-605.. |
|
| 2010年 |
|
木村豊・町田浩久・藤谷和正・山本守敏・谷口博一・矢野浩司・下川敏雄・瀧内比呂也・辻仲利政・古河 洋(2009). 腹膜転移を伴う高度進行・再発胃癌におけるS-1+Paclitaxel併用療法のFeasibility試験(OGSG0401), 癌と化学療法, 37(1), 151-155. |
|
| 2011年 |
|
S. Tamura, K. Fujitani, Y. Kimura, T. Tsuji, J. Matsuyama, . Iijima, H.
Imamura, K. Inoue, K. Kobayashi, Y. Kurokawa, and H. Furukawa: Phase II
feasibility study of adjuvant S-1 plus docetaxel for stage III gastric
cancer patients after curative D2 gastrectomy, Oncology, 90, 296-300, 2011. |
|
K. Inoue, Y Nakane, M. Kogire, K. Fujita, Y. Kimura, H. Imamura, S. Tamura,
S. Okano, AH Kwon, Y. Kurokawa, T. Shimokawa, H. Takiuchi, T Tsujinaka,
H. Furukawa: Phase II trial of preoperative S-1 plus cisplatin followed
by surgery for initially unresectable locally advanced gastric cancer.
Eur. J. Surg. Oncol., 38(2), 143-149. |
| 2012年 |
|
H. Imamura, Y. Kurokawa, T. T., K. Inoue, Y. Kimura, S. Iijima, T. Shimokawa,
H. Furukawa: Intraoperative versus extended antimicrobial prophylaxis after
gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority
trial, The Lancet Infectious Disease, 30 Jan, 2012. |
|
K. Fujitani1, T. Tsujinaka1, J. Fujita4, I. Miyashiro2, H. Imamura5, Y.
Kimura3, K. Kobayashi6, Y. Kurokawa7, T. Shimokawa8 and H. Furukawa: Prospective
randomized trial of preoperative enteral immunonutrition followed by elective
total gastrectomy for gastric cancer, British Journal of Surgery, 99, 621-629,
2012. |
|
Y. Kimura, H. Yano, H. Imamura, K. Fujitani, M. Imano, Y. Tokunaga, M. Matsuoka, Y. Kurokawa, T. Shimokawa, H. Takiuchi, T. Tsujinaka, H. Furukawa:A Phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer, Japanese Journal of Clinical Oncology, (in press) |
| 国際学会発表 |
| 2002年 |
|
Imamura H., Hiroshi Imamura, Hiroshi Furukawa, Hiroyuki Narahara, Kazumasa, Fujitani, Toshimasa Tsujinaka, Motohiro Imano, Kentaro Inoue, Seiichi, Sugihara: Phase II study of a combination of docetaxel and irinotecan in patients with advanced/recurrent gastric cancer. Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG: Protocol 0101. Clinical Investigators Update Meeting on Gastro-Intestinal Cance, Cheju Korea. |
|
| 2004年 |
|
Narahara H, Fujitani K, Tsujinaka T, Takiuchi H, Nakane K, Kato M, Kimura
Y, Tsukuma H, Furukawa H, Taguchi T. Phase I/II multicenter trial of S-1
plus paclitaxel in patients with metastatic gastric cancer: Osaka Gastrointestinal
Cancer Chemotheraoy Study Group Study (OGSG 0105). Annual meeting of American
Society of Clinical Oncology (ASCO). |
|
| 2005年 |
|
Imamura H., Furukawa H. et al.: Phase II study of a new regimen for S-1 therapy
aiming at adverse reaction mitigation for metastatic gastric cancer: a
study by the Osaka Gastrointestinal Chemotherapy Study Group OGSG-0103.
41th Anual Meeting of American Society of Clinical Oncology Congress, Orlando,
USA. |
|
Kii T, Takiuchi H, Imamura H, Kimura Y, Ishida H, Imano M, Nakane Y, Narahara
H, Tsujinaka T, Morimoto S, Ohta S, Kawabe S, Gotoh M, Furukawa H: Phase
II study of paclitaxel and doxifluridine in patients with S-1 failure gastric
cancer. 6th International Gastric Cancer Congress (6th IGCC). |
|
| 2006年 |
|
Kobayashi, K., Aoki, T., Furukawa, H., Tsujinaka, T., Takiuchi, H. Uedou,
F., Imamura, H., Iijima, S., Imano, M. and Shimokawa, T.Phase I/II Study
of weekly Taxol(TXL) plus CPT-11 for patients with advanced/recurrent gastic
cancer (AGC/RGC), 2006 Gastrical Cancers Symposum, American Society of
Clinical Oncology. |
|
H. Takiuchi, H. Imamura, M. Imano, Y. Kimura, H. Ishida, T. Tsujinaka,
H. Narahara, H. Furukawa. Multi-center, phase II study for combination
therapy with pacritaxel/doxifluridine to treat advanced/recurrent gastric
cancer showing resistance to S-1 (OGSG 0302), 2006 Gastrical Cancers Symposum,
American Society of Clinical Oncology. |
|
T. Kato, Y. Miyake, N. Tomita, H. Takiuchi, S. Kawabe, T. Tamura, H. Furukawa.
Phase I/II study of combination chemotherapy with UFT/LV + CPT-11 in patients
with advanced colorectal cancer (OGSG-0303), 2006 Gastrical Cancers Symposum,
American Society of Clinical Oncology. |
|
Imamura H., Furukawa H., Kishimoto T., Miyazaki Y., Yamamoto K., Nakae
S., Inoue K., Tsukahara Y., Imamoto M., Yamazaki K., Okano S., Morimoto
S., Sugihara S., Shimokawa T.: Muticenter Phase II Study of 2 Weeks Administration
with TS-1 Followed by 1 Week Rest against Metastatic Gastric Cancer. The
7th International Conference of Asian Clinical Oncology Society, Beijing,
China. |
|
| 2007年 |
|
Takiuchi H, Imamura H, Imano M, Kimura Y, Ishida H, Nakane Y, Tsujinaka
T, Narahara H, Morimoto S, Furukawa H. (2007) .Multi-center, phase II study
for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent
gastric cancer showing resistence to S-1: Final results (OGSG0302). 43rd
annual meeting of American society of clinical oncology (ASCO). |
|
Gotoh, M., Takiuchi, H., Imamura, H, Imano, M., Kimura, Y., Ishida, H.,
Tsujinaka, T., Narahara, T, Furukawa, H. Osaka Gastrointestinal Cancer
Chemotherapy Study Group: OGSG: Multi-Center Phase II Study for Combination
Therapy with Paclitaxel/Doxifluridine to Treat Advanced/Recurrent Gastric
Cancer Showing Resistance to S-1 (OGSG 0302). International Gastric cancer
Association |
|
| 2008年 |
|
Nakae,S., Hirao, M., Kishimoto, T., Iijima, S., Ishida, H., Morimoto, T.,
Imano, M., Goto, M., Uedo, N., Fujita, J. (2008). Phase II study of bi-weekly
CPT-11+CDDP for patients with gastric cancer refractory to S-1 (OGSG 0504
study), 44th annual meeting of American society of clinical oncology (ASCO). |
|
Otsuji1, T., Kato, T., Murata, K., Miyake, Y., Saraya, T., Matsuoka, M.,
Fukunaga, M., Furukawa, H.(2008). Preventive effect of Carbamazepine for
neurotoxicity of modified FOLFOX6 of metastatic colorectal cancer (mCRC):
a prospective phase II study (OGSG 0603 study), 2008 Gastrical Cancers
Symposum, American Society of Clinical Oncology. |
|
Y. Miyake, H. Ishida, M. Fukunaga, T. Kato, Y. Watanabe, H. Takemoto, H. Furukawa, Osaka gastrointestinal cancer chemotherapy study group (OGSG). (2008). A feasibility/phase II study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer (CRC) (OGSG 0304) , 44th annual meeting of American society of clinical oncology (ASCO). |
|
|
M. Imano, Y-F.Peng, H. Imamoto, H.Shiozaki, K K.Kobayashi, T. Aoki, H.Furukawa,
T.Tsujinaka, F. Uedo, H. Imamura, S. Iijima, T. Shimokawa, T. Taguchi(2008).
Phase I/II study of weekly taxol plus irinotecan for patients with advanced
of recurrent gastric cancer (OGSG0104). 7th International Gastric Cancer
Congress. |
|
|
Fujitani,K., Takiuchi,H., Sugimoto, N., Imamura,H. Iijima,S. Imano,M. Kimura,Y.,
Shimokawa,T., Kurokawa, Y., Tsujinaka,T. Furukawa, H. (2009). Randomized
phase II trial of S-1 plus irinotecanversus S-1 plus paclitaxelas first-line
treatment for advanced gastric cancer (OGSG0402), 2009 Gastrical Cancers
Symposum, American Society of Clinical Oncology. (Oral Presentation) |
|
| 2009年 |
|
Y,Kimura, H,Imamura, K,Inoue, K,Fujitani, Y,Miyake, J,Matsuyama, M,Tatsumi,
T,Shimokawa, Y,Kurokawa, H,Furukawa.(2009). Phase III Trail of perioperative
alone compared with perioperative plus postoperative antimicrobial prophylaxis
in gastric cancer surgery (OGSG0501), IGCC2009. |
|
|
Gotoh, H. Takiuchi, H. Imamura, Y. Kimura, T.Morimoto, M. Imano, S.Iijima,
K.Yamashita, M.Matsuoka, K.Maruyama, H. Furukawa.(2009).Phase II trial
of S-1 for elderly patients over 75 years with advanced gastric cancer
as first-line treatment ：OGSG0404. ESMO 2009. |
|
|
Yoshida, M., Sato, T., Takiuchi, H., Gotoh, M., Iijima, S., Nakae, S., Shimokawa, T., Kurokawa, Y., Hotta, A. and Furukawa, H.(2009). Phase II study of weekly paclitaxel as third-line chemotherapy
for advanced or recurrent gastric cancer : OGSG0602, ESMO2009. |
|
|
T. Kishimoto, H. Imamura, Y. Kimura, T. Tsujinaka, M. Imano, Y. Tokunaga,
M. Matsuoka, T. Shimokawa, Y. Kurokawa, H. Furukawa.(2010). Phase I study
of S-1, cisplatin, and paclitaxel in patients with advanced gastric cancer,
2010 Gastrical Cancers Symposum, American Society of Clinical Oncology. |
|
|
Y. Kimura, S. Tamura, K. Fujitani, T. Tsuji, J. Matsuyama, S. Iijima, H.
Imamura, K. Inoue, K. Kobayashi, Y. Kurokawa, H. Furukawa(2009).Phase II
feasibility study of adjuvant S-1 plus docetaxel for stage III gastric
cancer patients after curative D2 gastrectomy (OGSG 0604). ASCO-GI2010. |
|
|
Y. F. Peng, M. Imano, H. Imamoto, S. Tamura, K. Kobayashi, T. Shimokawa,
Y. Kurokawa, H. Takiuchi, T. Tsujinaka, H. Furukawa(2010),Phase II study
of docetaxel and cisplatin and fluorouracil for metastatic esophageal cancer,
2010 Gastrical Cancers Symposum, American Society of Clinical Oncology.
|
|
| 2010年 |
|
J. Fujita, T. Tsujinaka, T. Shimokawa, Y. Kurokawa, F. Fujitani, I.Miyashiro,
H. Imamura, Y. Kimura, K., Kobayashi, H. and H. Furukawa：A randomized controlled
trial to evaluate the effect of preoperative enteral immunonutrition on
the surgical site infection after total gastrectomy, 2010. |
|
|
S. Okano, Y. Nakane, K. Inoue, K. Fujitani, Y. Kimura, M. Kogire, M. Imano,
T. Shimokawa, Y. Kurokawa, H. Furukawa. (2010).A phase II study of systemic
chemotherapy with TS-1 combined with cisplatin followed by surgery in advanced
gastric cancer (OGSG0004). 2010, ASCO Annual Meeting. |
|
|
K. Fujitani, H. Takiuchi, N. Sugimoto, H. Imamura, S. Iijima, M. Imano,
Y. Kimura, T. Shimokawa, Y. Kurokawa, T. Tsujinaka, H. Furukawa: Randomized
phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxelas first-line
treatment for advanced gastric cancer (OGSG0402)ESMO Congress, Milan, Italia,
|
|
|
Y. Kurokawa, H. Imamura, K. Inoue, Y. Kimura, K. Fujitani, Y. Miyake, J.
Matsuyama, M. Tatsumi, T. Shimokawa, and H. Furukawa : A Randomized Controlled
Trial of Antimicrobial Prophylaxis Infusion after Gastric Cancer Surgery
(OGSG0501), ESMO Congress, Milan, Italia, Program No., 1235O (Oral Presentation). |
| 2012年 |
|
K. Fujitani, Y. Kimura, H. Imamura, M. Gotoh, S. Iijima, S. Ueda, M. Imano, M. Oshita, Y. Kurokawa, T. Shimokawa, H. Takiuchi, T. Tsujinaka, H. Furukawa:Multicenter phase II study of triplet combination chemotherapy with paclitaxel, cisplatin, and S-1 for advanced gastric cancer (OGSG 0703), ASCO-GI 2012. |
| 国内学会発表 |
| 2002年 |
|
今村博司・古河洋・岡野晋治・井上健太郎・中江史郎・龍田眞行・桝谷誠三・石田秀之・清水潤三・増田慎三・江角晃治・加藤仁・池田正孝: 進行再発胃癌に対するTS-1の2週投与1週休薬投与法. 第40回日本癌治療学会総会. |
|
| 2004年 |
|
井上健太郎他(2004)．TS-1/Paclitaxel併用療法における推奨用量と有効性および有害事象（胃癌を対象とした多施設共同I/II相臨床試験
(OGSG0105) ．第42回日本癌治療学会総会 |
|
石田秀之他. (2004).進行・再発大腸癌に対するCPT-11+UFT/LV併用化学療法の耐容性臨床試験（大阪消化管がん化学療法研究会、OGSG0304)．
第42回日本癌治療学会総会． |
|
| 2005年 |
|
今野元博・今本治彦・今村博司・瀧内比呂也・石田秀之・木村 豊・辻仲利政・楢原啓之・田村孝雄・中根恭司・原 章倫・福永浩紀・松本繁己・森本 卓・古河
洋. TS-1 治療抵抗性の進行・再発胃癌に対するPaclitaxel/Doxifluridine
併用療法の第 II 相臨床試験（OGSG 0302）．第47回癌治療学会総会. |
|
今村博司・古河洋ら: TS-1抵抗性進行・再発胃癌に対するPaclitaxel/Doxifluridine併用療法の第・相試験（OGSG0302・中間解析）.
第77回日本胃癌学会総会. |
|
今野元博・今村博司・古河洋ら: TS-1治療抵抗性の進行・再発胃がんに対するpaclitaxel/ doxifluridine 併用療法の第相臨床試験（OGSG
0302）. 第43回日本癌治療学会総会． |
|
| 2006年 |
|
今村博司・瀧内比呂也・今野元博・木村 豊・石田秀之・辻中利政・楢原啓之・中根恭司・森本 卓・田村孝雄・松本繁己・原 章倫・福永浩紀・下川敏雄・古河 洋.TS-1抵抗性の進行・再発胃癌に対するPaclitaxel/Doxifluridine併用療法の第Ⅱ相臨床試験 .第78回日本胃癌学会総会． |
|
小林研二・青木太郎・西岡清訓・古河 洋・辻中利政・瀧内比呂也・上堂文也・今村博司・飯島正平・今野元博・下川敏雄. 進行再発胃癌に対するWeekley投与によるTXL+CPT-11併用療法の第Ⅰ/Ⅱ相臨床試験
. 第78回日本胃癌学会総会． |
|
山本幸子・上堂文也・小林研二・青木太郎・古河 洋・辻仲利政・滝内比呂也・今村 博・飯島正平・今野元博・下川敏雄・田口鉄男. 進行再発胃癌に対するTXL+CPT-11併用療法の多施設共同第Ⅰ/Ⅱ相試験.
第4回 日本臨床腫瘍学会総会． |
|
辻仲利政、平尾素宏、藤谷和正、瀧内比呂也、古河洋、田口鐵男: 胃癌治療に対する大阪消化管がん化学療法研究会(OGSG)の取り組みの現状と展望.
第78回日本胃癌学会総会. |
|
田村孝雄・茶屋原菜穂子・奥野達哉・冨田尚裕・岡村修・中田健・瀧内比呂也・川部伸一郎・後藤昌弘・加藤健志・古河洋. (2006). 進行・再発大腸癌に対するUFT/LV+CPT-11併用化学療法の第I相試験(OGSG0303). 第4回日本臨床腫瘍学会総会. |
|
| 2007年 |
|
瀧内比呂也・今村博司・今野元博・木村豊・石田秀之・辻仲利政・楢原啓之・中根恭司・森本卓・田村孝雄・原章倫・福永浩紀・松本繁己13、古河洋(2006).TS-1抵抗性の進行・再発胃癌に対するPaclitaxel/Doxifluridine療法の第II相臨床試験（OGSG
0302），日本癌治療学会． |
|
|
冨田尚裕・岡村修・中田健・村田幸平・徳永行彦・梅木雅彦・瀧内比呂也・古河洋(2007).進行・再発大腸癌に対するCPT-11+S-1併用化学療法の第Ⅱ相試験，第79回日本癌治療学会． |
|
| 2008年 |
|
今村博司・飯島正平・平尾素宏・中江史郎・石田秀之・森本卓・今野元博・後藤昌弘・上堂文也・藤田淳也・岸本朋乃・宮崎安弘・下川敏雄・黒川幸典・瀧内比呂也・辻仲利政・古河洋(2008)．進行・再発胃癌に対する二次治療としてのCPT-11＋CDDP併用化学療法の第Ⅱ相臨床試験（OGSG
0504 ），第46回 日本癌治療学会 学術集会． |
|
|
後藤昌弘・瀧内比呂也・佐藤太郎・上田眞也・村田幸平・井出義人・松岡正樹・加藤健志・木村文彦・石田秀之・岩本慈能・田村孝雄・福永睦・下川敏雄・古河洋(2008)．化学療法既治療の治癒切除不能進行・再発大腸癌に対するL-OHP+5FU/l-LV(mFOLFOX6)療法の第II相臨床試験(OGSG
0505)，第6回 日本臨床腫瘍学会． |
|
|
村田幸平・大辻俊雄・加藤健志・三宅泰裕・更屋勉・松岡正樹・福永睦・古河洋(2008)．FOLFOX療法に伴う、末梢神経症状に対する
カルバマゼピンの有効性および安全性を検討する第2相臨床試験，第80回日本胃癌学会総会. |
|
|
今村博司・瀧内 比呂也・石田 秀之・飯島 正平・岸本 朋乃・宮崎 安弘・下川 敏雄・古河 洋(2008).TS-1単独、TS-1/CDDP併用療法に抵抗性の進行再発胃癌に対する二次治療の無作為化第II相試験（OGSG
0701）, 第80回日本胃癌学会総会． |
|
|
三宅泰裕他(2008). 進行・再発大腸癌に対するCPT-11＋UFT/LV（TEGAFIRI）併用化学療法の耐容性臨床試験（大阪消化器がん化学療法研究会、プルロトコールNo.
0304）.第63回日本消化器外科学会総会. |
|
| 2009年 |
|
木村豊・町田浩久・藤谷和正・山本守敏・矢野浩司・瀧内比呂也・辻仲利政・古河洋(2009)．腹膜転移を伴う高度進行・再発胃癌におけるTS-1/TXL併用療法の臨床第Ⅱ相試験(OGSG0401)，第81回日本胃癌学会総会. |
|
|
瀧内比呂也・藤谷和正・上堂文也・今村博司・今野元博・飯島正平・木村豊・黒川幸典・下川敏雄・後藤昌弘・杉本直俊・井上健太郎・辻仲利政・古河洋(2009).進行・再発胃癌に対するS-1＋CPT-11療法とS-1＋TXL療法とのランダム化比較第II相試験（OGSG0402），第7回日本臨床腫瘍学会学術集会. |
| 2010年 |
|
飯島正平・今村博司・木村豊・井上健太郎・藤谷和正・松山仁・辰巳満俊・下川敏雄・黒川幸典・古河洋(2010). 胃がんに対する幽門側胃切除の予防抗菌薬投与の必要性に関する第III相試験，第110回
日本外科学会． |
|
|
中江史朗・佐藤太郎・瀧内比呂也・飯島正平・岡本 渉・後藤昌弘・吉田元樹・半田理夫・辻仲利政・古河洋(2010) 進行,再発胃癌の3次治療でのPaclitaxel
weekly投与の安全性試験（OGSG0602)最終報告,48回 日本癌治療学会 学術集会 |
|
 |
